​
​

SeqLL Stock (NASDAQ:SQL)

OwnershipFinancialsChart
SeqLL by TradingView

Previous Close

$6.76

52W Range

$6.60 - $8.20

50D Avg

-

200D Avg

-

Market Cap

-

Avg Vol (3M)

-

Beta

1.29

Div Yield

-

SQL Company Profile

SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. The company designs, develops, and manufactures genetic analysis technologies. It offers true single molecule sequencing (tSMS) platform, which offers a single molecule solution for DNA and RNA sequencing. The company has a collaboration agreement with Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc. It serves academic and government institutions, hospitals and medical centers, pharmaceutical and biotechnology companies, and non-profit research organizations. The company was founded in 2013 and is based in Billerica, Massachusetts.

Show More

Industry

Medical - Diagnostics & Research

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

7

IPO Date

Aug 27, 2021

Website

SQL Performance

SQL Financial Summary

Dec 22Dec 21Dec 20
Revenue$1.18K$48.02K$50.59K
Operating Income$-4.00M$-2.55M$-949.72K
Net Income$-4.19M$-3.91M$-1.52M
EBITDA$-3.86M$-2.47M$-649.40K
Basic EPS$-14.11$-21.65$-12.53
Diluted EPS$-14.11$-21.65$-12.53

Fiscal year ends in Dec 22 | Currency in USD

Peer Comparison

TickerCompany
HTGMHTG Molecular Diagnostics, Inc.
BIOCBiocept, Inc.
GENEGenetic Technologies Limited
AAgilent Technologies, Inc.
ISPCiSpecimen Inc.
TTOOT2 Biosystems, Inc.
BIAFbioAffinity Technologies, Inc.
INBSIntelligent Bio Solutions Inc.